Page 38
FLASH will become the go-to choice of RT delivery Applicable to both RT and PT , we believe FLASH demonstrates significant upside to current delivery of radiation . The key upside to the high-dose , low-delivery time treatment is the increased therapeutic window which also predicts sparing of immune cells and thus a greater synergy with immuno-oncology techniques . Whilst only in clinical trial currently , all next-generation PT systems developed by the larger players are capable of delivering FLASH RT , thus indicating their belief in the future adoption of FLASH . As FLASH is also feasible in current photon RT systems with adjustments to LINACs , it appears the adoption of its use will be relatively simple once superior clinical outcomes are ratified .
Please see analyst certifications , important disclosure information , and information regarding the status of analysts on pages 91-94 of this research report .